Evidence of meeting #22 for International Trade in the 42nd Parliament, 1st Session. (The original version is on Parliament’s site, as are the minutes.) The winning word was tpp.

A recording is available from Parliament.

On the agenda

MPs speaking

Also speaking

Ronald Labonté  Professor and Canada Research Chair in Globalization and Health Equity, University of Ottawa, Canada Research Chairs Program
Declan Hamill  Chief of Staff and Vice President, Legal Affairs, Innovative Medicines Canada
Mark Fleming  Director, Federal Affairs and Health Policy at Janssen Inc., Innovative Medicines Canada
Carolyn Pullen  Director, Policy, Advocacy and Strategy, Canadian Nurses Association
Jim Keon  President, Canadian Generic Pharmaceutical Association
Dennis Prouse  Vice-President, Government Affairs, CropLife Canada
Richard Elliott  Executive Director, Canadian HIV/AIDS Legal Network
Jody Cox  Vice President, Federal and International Affairs, Canadian Generic Pharmaceutical Association
Arne Ruckert  Senior Research Associate, Globalization and Health Research Unit, University of Ottawa, Canada Research Chairs Program

10:25 a.m.

Vice-President, Government Affairs, CropLife Canada

Dennis Prouse

There was no change in the TPP for IP on seeds, nor were our members looking for any.

10:25 a.m.

Senior Research Associate, Globalization and Health Research Unit, University of Ottawa, Canada Research Chairs Program

Arne Ruckert

We would also agree with Mr. Elliott that certainly, our answer would be no, and we believe that the WTO agreement adequately protected intellectual property rights.

10:25 a.m.

Director, Policy, Advocacy and Strategy, Canadian Nurses Association

Dr. Carolyn Pullen

We haven't heard any arguments in favour, but I do defer to those who work in the industry.

10:25 a.m.

NDP

Tracey Ramsey NDP Essex, ON

Okay.

Mr. Fleming.

10:25 a.m.

Director, Federal Affairs and Health Policy at Janssen Inc., Innovative Medicines Canada

Mark Fleming

CETA has provided important IP enhancements that we have been leveraging very successfully. We're putting our money where our mouth is regarding attracting R and D investment to Canada and competing on the global stage for research and development investment.

10:25 a.m.

Chief of Staff and Vice President, Legal Affairs, Innovative Medicines Canada

Declan Hamill

It won't surprise you that there is also a yes column. I would just go back to a point made earlier by CGP on regulatory convergence and harmonization. We agree with that. It's a necessary but but it is not a sufficient condition. You also need to be competitive on IP, but certainly regulatory co-operation, as part of international trade agreements, is something we support, too.

10:25 a.m.

NDP

Tracey Ramsey NDP Essex, ON

Something we hear across a lot of industries is that harmonization is a really large issue. Whether we're able to get into these markets really isn't dependent upon some of these shifts, it's that we can't actually harmonize in a way to get into those markets. We certainly hear that repeated over and over across many different sectors.

Yes, Mr. Elliott.

10:25 a.m.

Liberal

The Chair Liberal Mark Eyking

It will have to be a quick answer.

10:25 a.m.

Executive Director, Canadian HIV/AIDS Legal Network

Richard Elliott

Yes.

I was going to say harmonization can be a good thing, but we shouldn't assume that it is. If you harmonize down to the lowest common denominator and you sacrifice to the public interest, that's not good harmonization. If Jimmy jumps off the bridge, it doesn't mean we should too, right?

10:25 a.m.

NDP

Tracey Ramsey NDP Essex, ON

We need to harmonize that.

10:25 a.m.

Liberal

The Chair Liberal Mark Eyking

Okay. That ends our morning.

Thanks to all the witnesses for coming with very different opinions in different sectors. It was a very fruitful discussion with the MPs. If you have any comments you couldn't get across, or anything else you think of, send it to our committee and we'll put it in our report.

We're going to suspend for three minutes now, because we're going in camera, so I ask everybody but the MPs to leave the room as soon as they can.

Thank you.

[Proceedings continue in camera]